Endometrial cancer in Thai women: Clinico-pathological presentation and survival

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 5, 2010, Pages 1267-1272

  Tangjitgamol, Siriwan ^a   Manusirivithaya, Sumonmal ^a   Srijaipracharoen, Sunamchok ^a   Khunnarong, Jakkapan ^a   Tanvanich, Sujitra ^a   Katanyu, Kanyarat ^a   Thavaramara, Thaovalai ^a   Pataradool, Kamol ^a  

^a Bangkok Metropolitan Administration   (Thailand)

Author keywords

Characteristic features; Endometrial cancer; Prognostic factors; Survivals

Indexed keywords

EID: 79955952449     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Altekruse SF, Kosary CL, Krapcho M, et al (2010). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, http,//seer.cancer.gov/csr/1975_2007/, Available at http,//seer.cancer.gov/statfacts/html/corp.html. Accessed July 4, 2010.
2. ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, et al (2009). Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials), pooled trial results, systematic review, and meta-analysis. Lancet, 373, 137-46.
3. Berchuck A, Boyd J (1995). Molecular basis of endometrial cancer. Cancer, 76, 2034-40.
4. Connell PP, Rotmensch J, Waggoner SE, et al (1999). Race and clinical outcome in endometrial carcinoma. Obstet Gynecol, 94, 713-20.
5. Eddy GL, Wojtowycz MA, Piraino PS, et al (1997). Papanicolaou smears by the Bethesda system in endometrial malignancy, utility and prognostic importance. Obstet Gynecol, 90, 999-1003.
6. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008, Cancer incidence and mortality worldwide, IARC Cancer base No. 10 (Internet). Lyon, France, international agency for research on cancer, 2010. Available at http,//globocan.iarc.fr/. Accessed July 4, 2010.
7. FIGO News (1989). Corpus Cancer Staging. Int J Gynecol Obstet, 28, 189-93.
8. Fukuda K, Mori M, Uchiyama M, et al (1999). Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance. Gynecol Oncol, 72, 2730-7.
9. Gruber S, Thompson W (1996). A population based study of endometrial cancer and familial risk in younger women. Cancer Epidemiol Biomarkers Prev, 5, 411-7.
10. Jeon YT, Park IA, Kim YB, et al (2006). Steroid receptor expressions in endometrial cancer, Clinical significance and epidemiological implication. Cancer Lett, 239, 98-204.
11. Klip H, Burger CW, Kenemans P, et al (2000). Cancer risk associated with subfertility and ovulation induction, a review. Cancer Causes Control, 11, 319-44.
12. Kodama J, Seki N, Ojima Y, et al (2005). Correlation of presenting symptoms and patient characteristics with endometrial cancer prognosis in Japanese women. Int J Gynecol Obstet, 91, 151-6.
13. Mariani A, Webb JM, Keeney LG, et al (2002). Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol, 86, 38-44.
14. Morris PC, Anderson JR, Anderson B, et al (1995). Steroid hormone receptor content and lymph node status in endometrial cancer. Gynecol Oncol, 56, 406-11.
15. Morrow P, Bundy BN, Kurman R J, et al (1991). Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium, a gynecological oncology group study. Gynecol Oncol, 40, 55-65.
16. Palmer DC, Muir IM, Alexander AI, et al (1988). The prognostic importance of steroid receptors in endometrial carcinoma. Obstet Gynecol, 72, 388-93.
17. Pecorelli S (2009). Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet, 105, 103-4.
18. Sherman ME (2000). Theories of endometrial carcinogenesis, a multidisciplinary approach. Mod Pathol, 13, 295-308.
19. Srijaipracharoen S, Tangjitgamol S, Tanvanich S, et al (2010). Expression of ER, PR, and her-2/ neu in endometrial cancer, a clinicopathological study. Asian Pac J Cancer Prev, 11, 215-20.
20. Susumu N, Sagae S, Udagawa Y, et al (2008). Japanese gynecologic oncology group. Randomized phase III trial of pelvis radiotherapy versus cisplatin- based combined chemotherapy in patients with intermediate and high risk endometrial cancer. A Japanese gynecologic oncology group study. Gynecol Oncol, 108, 226-33.
21. Wang JL, Wang ZQ, Wei LH (2004). Primary clinical analysis of medical disorders in Chinese women with endometrial carcinoma. Int J Cancer, 14, 502-7.
22. Weiderpass E, Persson I, Adami HO, et al (2000). Body size in different periods of life, diabetes mellitus, hypertension and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control, 11, 185-92.